TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Twist Bioscience Corp

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$139.77+7.02 (+5.29%)

Close on Oct 19, 2026

Community

Notes and questions about Twist Bioscience from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Twist Bioscience's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TWST.

Revenue growth19.2% · median 16.5%

Gross margin52.0% · median 64.7%

Operating margin-33.6% · median 43.8%

Net margin-31.7% · median 26.4%

Advertisement
300 × 250